Wieczorek I, Ludlam C A, MacGregor I R
Department of Haematology, Royal Infirmary of Edinburgh, UK.
Blood Coagul Fibrinolysis. 1994 Jun;5(3):329-34.
Some well-described similarities exist between tissue plasminogen activator (t-PA) and von Willebrand factor (vWf) which may suggest a link in either the synthesis or release of both proteins from endothelial cells. To investigate this relationship further immunocytochemical localization of t-PA and vWf was performed in normal tissues and in skin obtained from patients with type I and type III von Willebrand's disease (vWd). Components of the fibrinolytic system were measured at baseline and after venous occlusion in healthy controls and patients with vWd. Patients with severe vWd received intravenous vWf concentrate, followed by desmopressin (DDAVP), to study the plasma response of vWf and t-PA. By immunocytochemical staining, t-PA was demonstrated in endothelial cells of normal skin, kidney and liver and also in the skin of patients with type I and type III vWd. vWf was localized in endothelial cells of all tissues except the specimens from an individual with severe vWd. Basal plasma levels of fibrinolytic components were normal in patients with vWd. Venous occlusion resulted in a rise of fibrinolytic activity in controls and patients with type I, but not type III, vWd. No rise in plasma t-PA was observed following DDAVP in severe vWd, even though near-normalization of plasma vWf levels had been obtained by prior infusion of vWf concentrate. It is concluded that the synthesis of t-PA and vWf is probably regulated by independent processes. Constitutive and regulated release of both proteins occur through different mechanisms and the basal secretion of t-PA is intact in severe vWd.(ABSTRACT TRUNCATED AT 250 WORDS)
组织型纤溶酶原激活物(t-PA)和血管性血友病因子(vWf)之间存在一些已被充分描述的相似之处,这可能暗示这两种蛋白质在内皮细胞的合成或释放过程中存在联系。为了进一步研究这种关系,对正常组织以及I型和III型血管性血友病(vWd)患者的皮肤进行了t-PA和vWf的免疫细胞化学定位。在健康对照者和vWd患者中,于基线和静脉阻塞后测量了纤溶系统的成分。重度vWd患者接受静脉注射vWf浓缩物,随后注射去氨加压素(DDAVP),以研究vWf和t-PA的血浆反应。通过免疫细胞化学染色,在正常皮肤、肾脏和肝脏的内皮细胞中以及I型和III型vWd患者的皮肤中均检测到t-PA。vWf定位于除一名重度vWd患者的标本外的所有组织的内皮细胞中。vWd患者的纤溶成分基础血浆水平正常。静脉阻塞导致对照组和I型vWd患者(而非III型vWd患者)的纤溶活性升高。在重度vWd患者中,注射DDAVP后未观察到血浆t-PA升高,尽管先前输注vWf浓缩物已使血浆vWf水平接近正常。结论是,t-PA和vWf的合成可能受独立过程调节。这两种蛋白质的组成性和调节性释放通过不同机制发生,且重度vWd患者中t-PA的基础分泌是完整的。(摘要截取自250字)